{"id":9130,"date":"2021-11-16T15:41:23","date_gmt":"2021-11-16T15:41:23","guid":{"rendered":"http:\/\/cvx.vc\/?p=9130"},"modified":"2021-11-16T15:41:23","modified_gmt":"2021-11-16T15:41:23","slug":"danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab","status":"publish","type":"post","link":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/","title":{"rendered":"Danske investeringsfonde laver millard-exit i finsk BioTech-selskab"},"content":{"rendered":"<p>V\u00e6kstvirksomheden Forendo Pharma, der har danske Novo Seeds og Sunstone i ejerkredsen, er blevet solgt til amerikanske Organon for 6,2 mia. kr. Forendo Pharma har udviklet en behandlingsform til endometriose. Endometriose er en kronisk tilstand, der p\u00e5virker op til 10% af kvinder i den reproduktive alder og for\u00e5rsager gentagne smertesymptomer, infertilitet og nedsat livskvalitet.<\/p>\n<p><em>&#8220;Det er en super deal for os. Vi er meget tilfredse med udfaldet. Vi har st\u00f8ttet op om selskabet gennem hele rejsen, og vi er som sagt ganske godt tilfredse med \u00f8konomien i aftalen,&#8221;<\/em> udtaler S\u00f8ren M\u00f8ller, Managing Director hos Novo Holdings, til MedWatch.<\/p>\n<p>Forendo Pharma blev stiftet i 2013 af Risto Lammintausta, Pasi Koskimies og Kira Wahlstedt-Lindstr\u00f6m og besk\u00e6ftiger i dag 27 medarbejdere. Nu vil Organon betale 500 mio. kr nu, som skal afbetale v\u00e6kstkometens g\u00e6ld, og samtidig finansiere udviklingen og kommercialiseringen af l\u00e6gemidlet FOR-6219.<\/p>\n<p>L\u00e6s hele artiklen p\u00e5 MedWatch <a href=\"https:\/\/medwatch.dk\/Medicinal___Biotek\/article13457560.ece\"><em><strong>her<\/strong><\/em><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>V\u00e6kstvirksomheden Forendo Pharma, der har danske Novo Seeds og Sunstone i ejerkredsen, er blevet solgt til amerikanske Organon for 6,2 mia. kr.\u00a0Forendo Pharma har udviklet en behandlingsform til endometriose.<\/p>\n","protected":false},"author":25,"featured_media":9133,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[18],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.4 (Yoast SEO v23.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Danske investeringsfonde laver millard-exit i finsk BioTech-selskab | CVX Ventures<\/title>\n<meta name=\"description\" content=\"V\u00e6kstvirksomheden Forendo Pharma, der har danske Novo Seeds og Sunstone i ejerkredsen, er blevet solgt til amerikanske Organon for 6,2 mia. kr.\u00a0Forendo Pharma har udviklet en behandlingsform til endometriose.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Danske investeringsfonde laver millard-exit i finsk BioTech-selskab\" \/>\n<meta property=\"og:description\" content=\"V\u00e6kstvirksomheden Forendo Pharma, der har danske Novo Seeds og Sunstone i ejerkredsen, er blevet solgt til amerikanske Organon for 6,2 mia. kr.\u00a0Forendo Pharma har udviklet en behandlingsform til endometriose.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/\" \/>\n<meta property=\"og:site_name\" content=\"CVX Ventures\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cvxventures\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-16T15:41:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/11\/Forendo-Pharma.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"790\" \/>\n\t<meta property=\"og:image:height\" content=\"444\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kim Jessica Axholt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Jessica Axholt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/\"},\"author\":{\"name\":\"Kim Jessica Axholt\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\"},\"headline\":\"Danske investeringsfonde laver millard-exit i finsk BioTech-selskab\",\"datePublished\":\"2021-11-16T15:41:23+00:00\",\"dateModified\":\"2021-11-16T15:41:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/\"},\"wordCount\":160,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/11\/Forendo-Pharma.jpg\",\"articleSection\":[\"Blogindl\u00e6g\"],\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/\",\"url\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/\",\"name\":\"Danske investeringsfonde laver millard-exit i finsk BioTech-selskab | CVX Ventures\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/11\/Forendo-Pharma.jpg\",\"datePublished\":\"2021-11-16T15:41:23+00:00\",\"dateModified\":\"2021-11-16T15:41:23+00:00\",\"description\":\"V\u00e6kstvirksomheden Forendo Pharma, der har danske Novo Seeds og Sunstone i ejerkredsen, er blevet solgt til amerikanske Organon for 6,2 mia. kr.\u00a0Forendo Pharma har udviklet en behandlingsform til endometriose.\",\"breadcrumb\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#primaryimage\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/11\/Forendo-Pharma.jpg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/11\/Forendo-Pharma.jpg\",\"width\":790,\"height\":444},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\/\/cvx.vc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Danske investeringsfonde laver millard-exit i finsk BioTech-selskab\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cvx.vc\/da\/#website\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"name\":\"CVX Ventures\",\"description\":\"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder\",\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cvx.vc\/da\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cvx.vc\/da\/#organization\",\"name\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"width\":827,\"height\":394,\"caption\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/cvxventures\/\",\"https:\/\/www.linkedin.com\/company\/cvxventures\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\",\"name\":\"Kim Jessica Axholt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"caption\":\"Kim Jessica Axholt\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Danske investeringsfonde laver millard-exit i finsk BioTech-selskab | CVX Ventures","description":"V\u00e6kstvirksomheden Forendo Pharma, der har danske Novo Seeds og Sunstone i ejerkredsen, er blevet solgt til amerikanske Organon for 6,2 mia. kr.\u00a0Forendo Pharma har udviklet en behandlingsform til endometriose.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/","og_locale":"da_DK","og_type":"article","og_title":"Danske investeringsfonde laver millard-exit i finsk BioTech-selskab","og_description":"V\u00e6kstvirksomheden Forendo Pharma, der har danske Novo Seeds og Sunstone i ejerkredsen, er blevet solgt til amerikanske Organon for 6,2 mia. kr.\u00a0Forendo Pharma har udviklet en behandlingsform til endometriose.","og_url":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/","og_site_name":"CVX Ventures","article_publisher":"https:\/\/www.facebook.com\/cvxventures\/","article_published_time":"2021-11-16T15:41:23+00:00","og_image":[{"width":790,"height":444,"url":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/11\/Forendo-Pharma.jpg","type":"image\/jpeg"}],"author":"Kim Jessica Axholt","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"Kim Jessica Axholt","Estimeret l\u00e6setid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#article","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/"},"author":{"name":"Kim Jessica Axholt","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb"},"headline":"Danske investeringsfonde laver millard-exit i finsk BioTech-selskab","datePublished":"2021-11-16T15:41:23+00:00","dateModified":"2021-11-16T15:41:23+00:00","mainEntityOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/"},"wordCount":160,"commentCount":0,"publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/11\/Forendo-Pharma.jpg","articleSection":["Blogindl\u00e6g"],"inLanguage":"da-DK","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/","url":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/","name":"Danske investeringsfonde laver millard-exit i finsk BioTech-selskab | CVX Ventures","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#primaryimage"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/11\/Forendo-Pharma.jpg","datePublished":"2021-11-16T15:41:23+00:00","dateModified":"2021-11-16T15:41:23+00:00","description":"V\u00e6kstvirksomheden Forendo Pharma, der har danske Novo Seeds og Sunstone i ejerkredsen, er blevet solgt til amerikanske Organon for 6,2 mia. kr.\u00a0Forendo Pharma har udviklet en behandlingsform til endometriose.","breadcrumb":{"@id":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#primaryimage","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/11\/Forendo-Pharma.jpg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2021\/11\/Forendo-Pharma.jpg","width":790,"height":444},{"@type":"BreadcrumbList","@id":"https:\/\/cvx.vc\/da\/insights\/danske-investeringsfonde-laver-millard-exit-i-finsk-biotech-selskab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/cvx.vc\/"},{"@type":"ListItem","position":2,"name":"Danske investeringsfonde laver millard-exit i finsk BioTech-selskab"}]},{"@type":"WebSite","@id":"https:\/\/cvx.vc\/da\/#website","url":"https:\/\/cvx.vc\/da\/","name":"CVX Ventures","description":"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder","publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cvx.vc\/da\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Organization","@id":"https:\/\/cvx.vc\/da\/#organization","name":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor","url":"https:\/\/cvx.vc\/da\/","logo":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","width":827,"height":394,"caption":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor"},"image":{"@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cvxventures\/","https:\/\/www.linkedin.com\/company\/cvxventures\/"]},{"@type":"Person","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb","name":"Kim Jessica Axholt","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","caption":"Kim Jessica Axholt"}}]}},"_links":{"self":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/9130"}],"collection":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/comments?post=9130"}],"version-history":[{"count":0,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/9130\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media\/9133"}],"wp:attachment":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media?parent=9130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/categories?post=9130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/tags?post=9130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}